drugset / Trial / NCT05492669

Intravenous Lidocaine on Chronic Pain in Patients Undergoing Hepatectomy

NCT05492669

Phase 2 Unknown 260 enrolled West China Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a further observation and follow-up of the patients enrolled in the registration number NCT04295330 to further evaluate the effect of long-term infusion of lidocaine on postoperative chronic pain, long-term quality of life and survival rate in patients undergoing liver cancer surgery.

Timeline

Start
2020-02-27
Primary completion
2024-07-27
Completion
2024-07-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg
Subject Lidocaine Other / unclassified 30 mg/kg

Indications